Subscribe
man_at_mouse
man_at_mouse / iStockphoto.com
7 February 2019Biotechnology

Victory for Mayo in neurological disorder patent dispute

In a victory for Mayo Collaborative Services, a US Court has ruled that four claims in a patent, of which Athena Diagnostics is the exclusive licensee, are invalid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Federal Circuit refuses to rehear Athena dispute; judges call for reform
4 July 2019   The US Court of Appeals for the Federal Circuit has upheld a win for Mayo Collaborative Services after it denied Athena Diagnostics’ petition to have a neurological patent dispute reheard en banc.
Big Pharma
Athena asks for rehearing on invalidated neurological disorder patent
9 April 2019   Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.
Americas
Amerigen loses patent case against UCB at Federal Circuit
14 January 2019   US-based Amerigen Pharmaceuticals has lost in its bid to prove that claims in a patent owned by biopharmaceutical company UCB were covered by a prior invention.


Editor's picks

Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
Americas
Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
3 April 2025

Editor's picks

Americas
Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
3 April 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025
Americas
LSPN finalists revealed for first-ever US awards
3 March 2025

More on this story

Americas
Federal Circuit refuses to rehear Athena dispute; judges call for reform
4 July 2019   The US Court of Appeals for the Federal Circuit has upheld a win for Mayo Collaborative Services after it denied Athena Diagnostics’ petition to have a neurological patent dispute reheard en banc.
Big Pharma
Athena asks for rehearing on invalidated neurological disorder patent
9 April 2019   Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.
Americas
Amerigen loses patent case against UCB at Federal Circuit
14 January 2019   US-based Amerigen Pharmaceuticals has lost in its bid to prove that claims in a patent owned by biopharmaceutical company UCB were covered by a prior invention.

More on this story

Americas
Federal Circuit refuses to rehear Athena dispute; judges call for reform
4 July 2019   The US Court of Appeals for the Federal Circuit has upheld a win for Mayo Collaborative Services after it denied Athena Diagnostics’ petition to have a neurological patent dispute reheard en banc.
Big Pharma
Athena asks for rehearing on invalidated neurological disorder patent
9 April 2019   Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.
Americas
Amerigen loses patent case against UCB at Federal Circuit
14 January 2019   US-based Amerigen Pharmaceuticals has lost in its bid to prove that claims in a patent owned by biopharmaceutical company UCB were covered by a prior invention.

More features

Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
Mental health IP toolkit: Diversity Champ’s stress-busting tips
Eli Lilly piles on weight loss drug suits to ward off revenue squeeze
Patent cliff: 5 blockbusters running out of road
Herbert Smith Freehills expands German tech patent team
‘Always new twists’: Bayer legal team on defending a $4bn drug
Novartis and MSN feud intensifies after Fed Circ denies rehearing
EU court signals tough stance on ‘pay-for-delay’ pharma deals